Clinical efficacy and safety of intravenous pantoprazole in gastroesophageal reflux disease (GERD).

被引：2
|
作者：
Wurzer, H
Schütze, K
Kratochvil, P
Stupnicki, T
机构：
[1] Gen Hosp, Dept Med 2, Graz, Austria
[2] Hanusch Hosp, Dept Med 1, Vienna, Austria
[3] Styrian Hlth Insurance Fund, Graz, Austria
[4] Gen Hosp, Dept Med, Deutschlandsberg, Austria
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)81357-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1367
引用
收藏
页码：A334 / A335
页数：2
相关论文
共 50 条
  • [21] Intravenous Pantoprazole as Initial Treatment in Patients With Gastroesophageal Reflux Disease and a History of Erosive Esophagitis: A Randomized Clinical Trial
    Vijaya Pratha
    Daniel L. Hogan
    Richard B. Lynn
    Brian Field
    David C. Metz
    Digestive Diseases and Sciences, 2006, 51 : 1595 - 1601
  • [22] Clinical Study on the Efficacy of Pantoprazole Combined with Mosapride on Gastroesophageal Reflux Chest Pain
    Chang Hui
    Yingqiang, G.
    Yang Zhicai
    Xiaokang, N.
    Yue Liming
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 42 - 45
  • [23] An open-label, multicenter study of rabeprazole safety and efficacy for gastroesophageal reflux disease (GERD) in adolescents
    Lu, Yufang
    Gunasekaran, Thirumazhisai
    Haddad, Ibrahim
    Varughese, Shanti
    Kao, Richard
    Thompson, Caroline
    Rossiter, Guillermo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S27 - S27
  • [24] Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: A randomized clinical trial
    Pratha, Vijaya
    Hogan, Daniel L.
    Lynn, Richard B.
    Field, Brian
    Metz, David C.
    DIGESTIVE DISEASES AND SCIENCES, 2006, 51 (09) : 1595 - 1601
  • [25] Clinical efficacy and safety of an intravenous (i.v.) pantoprazole formulation in erosive reflux esophagitis.
    Plein, K
    Hotz, J
    Fischer, R
    Schneider, A
    GASTROENTEROLOGY, 1997, 112 (04) : A260 - A260
  • [26] Pharmacodynamics (PD) and Safety of Pantoprazole Delayed-Release Granules in Infants Aged 1 Through 11 Months with a Clinical Diagnosis of Gastroesophageal Reflux Disease (GERD)
    Comer, Gail M.
    Kierkus, Jaroslaw
    Sullivan, Janice E.
    Furmaga-Jablonska, Wanda
    Rath, Natalie J.
    Fu, Caifeng
    Wang, Wenjin
    Maguire, Mary K.
    GASTROENTEROLOGY, 2009, 136 (05) : A443 - A444
  • [27] A new integrated approach for assessing the effectiveness of pantoprazole and esomeprazole treatment in patients with gastroesophageal reflux disease (GERD)
    Achim, A
    Riddermann, T
    Bethke, TD
    Pfaffenberger, B
    GASTROENTEROLOGY, 2005, 128 (04) : A528 - A528
  • [28] The effect of pantoprazole versus placebo on gastroesophageal reflux disease (GERD) related symptoms other than heartburn
    Fass, Ronnie
    Bothe, Gordana
    Heinze, Hartmut
    Monnikes, Hubert
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB196 - AB196
  • [29] Intravenous application of pantoprazole in routine clinical practice - Safety and efficacy
    Bosseckert, H
    Gatz, G
    Braun, W
    GASTROENTEROLOGY, 1999, 116 (04) : A126 - A126
  • [30] CLINICAL AND RADIOGRAPHIC FINDINGS ARE UNRELIABLE TO DIAGNOSE GASTROESOPHAGEAL REFLUX DISEASE (GERD)
    PATTI, MG
    BORTOLASI, L
    ARCERITO, M
    TONG, J
    MURGIA, AP
    WAY, LW
    GASTROENTEROLOGY, 1995, 108 (04) : A1238 - A1238
12345